Apr 21, 2022
Impel Celebrates Its One-Year Anniversary as a Public Company SEATTLE, April 21, 2022 (GLOBE NEWSWIRE) -- Impel NeuroPharma (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial
Displaying 1 - 10 of 12